United-Guardian (NASDAQ:UG) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of United-Guardian (NASDAQ:UG) in a research note released on Wednesday. The firm issued a buy rating on the stock.

United-Guardian Trading Up 0.4 %

Shares of NASDAQ UG opened at $8.06 on Wednesday. United-Guardian has a one year low of $7.73 and a one year high of $16.25. The business has a 50-day moving average price of $8.82 and a two-hundred day moving average price of $10.00. The firm has a market capitalization of $37.03 million, a PE ratio of 10.61 and a beta of 0.95.

United-Guardian (NASDAQ:UG) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.12 earnings per share for the quarter. The business had revenue of $2.48 million for the quarter. United-Guardian had a net margin of 28.30% and a return on equity of 30.25%.

Institutional Investors Weigh In On United-Guardian

Institutional investors and hedge funds have recently modified their holdings of the business. Heron Bay Capital Management acquired a new stake in shares of United-Guardian in the fourth quarter worth $135,000. United Capital Financial Advisors LLC acquired a new stake in shares of United-Guardian in the fourth quarter valued at about $192,000. Northern Trust Corp increased its stake in shares of United-Guardian by 69.5% in the fourth quarter. Northern Trust Corp now owns 25,527 shares of the company’s stock worth $244,000 after purchasing an additional 10,466 shares during the period. Geode Capital Management LLC lifted its position in shares of United-Guardian by 10.3% during the 4th quarter. Geode Capital Management LLC now owns 31,264 shares of the company’s stock worth $302,000 after purchasing an additional 2,929 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of United-Guardian by 4.3% during the fourth quarter. Renaissance Technologies LLC now owns 190,163 shares of the company’s stock worth $1,818,000 after buying an additional 7,800 shares during the last quarter. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.